|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. see also National Cancer Data Base; Surveillance, Epidemiology, and End Results program Cancer Surveillance Research Program, 185 Centers for Disease Control and Prevention, 11, 18-19, 49, 154, 180 , 185, 197-199, 224 Cervical cancer, 11, 14, 22, 42, 51, 171, 187, 189, 190, 192, 193 Pap smears, 22, 51, 54-55, 56, 57, 190 Cervical Cancer Early Detection Program, 11 Chemotherapy, 3, 4, 22, 23, 30, 31, 49, 58, 60, 62, 82, 83, 88, 217 breast cancer, 60, 82, 94-95, 96, 98-99, 109, 129, 167, 171, 173, 174 clinical practice guidelines, 166, 169-170, 173, 174 international perspectives, 171-172 prostate cancer, 107 side-effects, 24 specialty care and, 128, 129, 130, 131 standards, 164 see also Drugs Children, 19, 49, 188, 195-196, 206 incidence, 20 Clinical practice guidelines, 4-5, 7-8, 15, 18, 23, 34, 43, 62, 64 -65, 99, 119, 133, 144, 148, 154-155, 164-174, 175, 195, 212, 220 American Society of Clinical Oncology, 26, 166-167 breast cancer, 99, 165, 166, 167, 169, 171, 173, 174 chemotherapy, 166, 169-170, 173, 174 colorectal cancer, 166, 169, 171, 172, 173, 174 defined, 164-165 lung cancer, 166-167, 169, 172 managed care, 172 patient education, 165, 168, 173 proprietary, 166 prostate cancer, 165, 170-171, 172 surgery, 99, 133, 166, 167, 170-171, 172 Clinical trials, 4, 8, 23, 62-63, 117, 129, 146, 181, 182, 187, 191 , 194-195, 200, 213, 217, 220, 221 international perspectives, 34 postoperative survival, 83 prostate cancer, 103 standards, 162 Cochrane Collaboration, 207, 208-209 adjuvant therapy, 173 clinical practice guidelines, 166, 169, 171, 172, 173, 174 incidence, 20 minorities, 47 screening, 22, 42, 51, 54, 57, 58, 193, 198, 199, 203, 205 treatment, 27, 28, 30, 31, 61, 82, 83, 88, 132-133, 153, 156, 173, 203, 204 Community Clinical Oncology Program, 34, 99 Community Hospital Oncology Program, 168-169 Complementary treatments, 24, 204 Continuous quality improvement programs, 163-164 Cooperative Group Program, 34 Coordination of care, 7, 26, 30, 41, 46, 214, 215, 220 disease management specialists, 40-41, 133 Costs, 20, 35-36, 182, 194, 206 age factors, 36 breast cancer, 36 clinical practice guidelines, 172-173 disease management specialists, 40-41, 133 individual patient, 10, 20, 35, 47, 48, 50, 64 insurance premiums, 47, 48, 50, 52 national costs of cancer, general, 20, 35-36, 41 out-of-pocket, 50, 52, 57, 59, 64, 66
|
|
|||||||||||||||
